Lido Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$632K Sell
2,816
-1,603
-36% -$399K ﹤0.01% 1177
2025
Q4
$1.2M Sell
4,419
-70
-2% -$17.9K ﹤0.01% 931
2025
Q3
$1.23M Buy
4,489
+407
+10% +$111K ﹤0.01% 864
2025
Q2
$1.05M Sell
4,082
-355
-8% -$84.7K ﹤0.01% 823
2025
Q1
$993K Buy
4,437
+486
+12% +$113K ﹤0.01% 781
2024
Q4
$904K Buy
3,951
+503
+15% +$121K ﹤0.01% 797
2024
Q3
$842K Buy
3,448
+629
+22% +$141K ﹤0.01% 783
2024
Q2
$540K Buy
2,819
+709
+34% +$144K ﹤0.01% 902
2024
Q1
$418K Buy
2,110
+361
+21% +$66.1K ﹤0.01% 957
2023
Q4
$301K Buy
1,749
+123
+8% +$18.9K ﹤0.01% 1033
2023
Q3
$240K Buy
1,626
+145
+10% +$26.2K ﹤0.01% 1010
2023
Q2
$324K Sell
1,481
-18
-1% -$4.01K ﹤0.01% 892
2023
Q1
$328K Buy
1,499
+434
+41% +$94.2K ﹤0.01% 842
2022
Q4
$222K Sell
1,065
-76
-7% -$16.7K ﹤0.01% 878
2022
Q3
$249K Buy
1,141
+62
+6% +$14.1K ﹤0.01% 829
2022
Q2
$226K Buy
1,079
+4
+0.4% +$852 ﹤0.01% 832
2022
Q1
$260K Buy
1,075
+62
+6% +$15K ﹤0.01% 859
2021
Q4
$263K Buy
1,013
+49
+5% +$12.7K ﹤0.01% 860
2021
Q3
$254K Buy
964
+49
+5% +$13.4K ﹤0.01% 806
2021
Q2
$226K Buy
+915
New +$192K ﹤0.01% 822
2020
Q3
Sell
-1,598
Closed -$307K 683
2020
Q2
$307K Buy
+1,598
New +$261K 0.01% 443

Other funds holding RMD

Lido Advisors's RMD Position: Q1 2026 in Review

Lido Advisors reduced its ResMed (RMD) stake by 36% in Q1 2026, selling an estimated $399K and leaving 2,816 shares worth $632K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

Lido Advisors first reported a position in RMD in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.23M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Lido Advisors held 2,816 shares of ResMed worth $632K as of Q1 2026.
  • Lido Advisors sold 1,603 ResMed shares in Q1 2026, an estimated $399K.
  • ResMed made up ﹤0.01% of Lido Advisors's portfolio in Q1 2026, its #1177 holding.
  • Lido Advisors first reported a position in ResMed in Q2 2020 and has held it in 21 quarters since.
  • Lido Advisors's ResMed position peaked at $1.23M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.